Latest

psychopharmacology

·September 27, 2023·5 min read

Mood Dips During Pill Pause

Research reveals that women's mood can decline during the 7-day pill-free interval of contraceptive cycles. The study evaluated the mental health of long-term pill users and found heightened anxiety and negative feelings during this pause.

Featured Neuroscience Psychology

·September 13, 2023·4 min read

Antidepressants May Boost Memory Function and Reduce Negative Memories

A new study delves into the relationship between antidepressants and memory dynamics. The study reveals that these drugs may dampen negative memories and bolster overall memory function in individuals with depression.

This shows mushrooms and a person looking at them.

Featured Neuroscience Psychology

·September 7, 2023·4 min read

Psilocybin and Mental Health: A Glimpse into Psychedelic Therapeutics

Psychedelic drugs, notably psilocybin found in "magic mushrooms," are under the spotlight for their potential to treat various mental health disorders. Recent studies reveal promising outcomes using psilocybin for major depressive disorder (MDD) and treatment-resistant depression (TRD).

Featured Neuroscience Psychology

·August 29, 2023·6 min read

Treating Mom’s Postnatal Depression with SSRIs Also Boosts Child Behavior

A new study found that treating postnatal depression with selective serotonin reuptake inhibitors (SSRIs) benefits not just mothers but also their children. The study, which analyzed data from over 61,000 mothers and their children, shows that SSRI treatment led to better outcomes up to five years after childbirth.

Featured Neuroscience Psychology

·August 25, 2023·2 min read

Ketamine in Depression Treatment: Balancing Promise with Caution

Researchers examined the evolving use of ketamine as a treatment for depression in New Zealand. While acknowledging its potential benefits for treatment-resistant depression, they advise against a rapid large-scale increase in its use.

Featured Neuroscience Psychology

·August 8, 2023·6 min read

Psychedelics Sync Neurons: A Glimpse into Consciousness & Psychosis

Researchers have pioneered a method to simultaneously measure electrical signals from 128 brain regions in conscious rats. Using this technique, they observed the effects of psychedelic drugs, LSD and ketamine, on the brain's neural oscillations.

Featured Neuroscience Psychology

·August 3, 2023·5 min read

GABA Receptors Unveiled as Potential Antidepressant Targets

A new study argues the neurotransmitter GABA and its principal receptors could play a key role in managing depressive disorders. Researchers suggest potential pathways through which GABA-modulating treatments could alleviate both cognitive and affective symptoms linked to depression.

Featured Neuroscience Psychology

·August 3, 2023·6 min read

Extended Antidepressant Therapy Curbs Relapses in Bipolar Disorder

Researchers lead a global clinical trial suggesting that long-term use of modern antidepressants could reduce depressive relapses in patients with bipolar disorder. This challenges current clinical practice guidelines and might significantly change how bipolar depression is treated worldwide.

Featured Neuroscience Psychology

·July 28, 2023·5 min read

Journeys Beyond: Contrasting Psychedelic Trips and Near-Death Experiences

A research study scrutinizes the parallels and differences between a near-death experience (NDE) during a coma and the experience induced by a potent psychedelic drug, 5-Methoxy-DMT (5MeO-DMT). The researchers found shared themes, such as ego dissolution and space-time transcendence.

Featured Neuroscience Psychology

·July 18, 2023·4 min read

Study Challenges Longstanding Beliefs About Action of Antipsychotic Medications

Researchers uncovered a pivotal detail that could revolutionize schizophrenia treatment. Contrary to longstanding belief, antipsychotic drugs that mitigate overactive dopamine, a hallmark of schizophrenia, interact primarily with a different type of neuron than originally assumed.

Featured Neuroscience Psychology

·July 14, 2023·6 min read

New Dads with Prior Antidepressant Use 30x More Likely to Restart Treatment

New fathers with a history of antidepressant use are over 30 times more likely to require such treatment again in the first year after their child's birth. The study, which analyzed over 500,000 primary care electronic health records, found no difference in antidepressant treatment between new fathers and men who hadn't recently had a child, except when a history of treatment was considered.

Featured Neuroscience Psychology

·July 12, 2023·7 min read

Psychedelic Breakthrough: MDMA Revolutionizes PTSD Treatment

Psychedelic therapies, including the use of MDMA, are set to revolutionize psychiatric treatments, especially for those with post-traumatic stress disorder (PTSD). The anticipation builds for the FDA's approval of MDMA-assisted therapy for PTSD, which will mark a first for a psychedelic drug in mainstream medicine.

1 2 3 … 32

psychopharmacology

Mood Dips During Pill Pause

Antidepressants May Boost Memory Function and Reduce Negative Memories

Psilocybin and Mental Health: A Glimpse into Psychedelic Therapeutics

Treating Mom’s Postnatal Depression with SSRIs Also Boosts Child Behavior

Ketamine in Depression Treatment: Balancing Promise with Caution

Psychedelics Sync Neurons: A Glimpse into Consciousness & Psychosis

GABA Receptors Unveiled as Potential Antidepressant Targets

Extended Antidepressant Therapy Curbs Relapses in Bipolar Disorder

Journeys Beyond: Contrasting Psychedelic Trips and Near-Death Experiences

Study Challenges Longstanding Beliefs About Action of Antipsychotic Medications

New Dads with Prior Antidepressant Use 30x More Likely to Restart Treatment

Psychedelic Breakthrough: MDMA Revolutionizes PTSD Treatment

Circadian Rhythm Off Beat: Parkinson’s and Nighttime Neuron Damage

ChatGPT’s Role in Shaping Identity and Personal Narratives

New Brain Structures in Language Processing Identified

Subscribe